Drug intelligence / Profile preview

Kaspro SF

Development stage: Unknown
Lead developer: Kaiser Drugs
Modality: Recombinant Proteins and Enzymes, Small Molecules
Administration: Oral

Overview

Kaspro SF is a sugar-free protein supplement powder distributed by Kaiser Drugs. It is formulated to provide nutritional support, containing a blend of proteins, vitamins, and minerals. It is typically used as a dietary supplement to address nutritional deficiencies, support recovery after illness, and provide extra protein during pregnancy or lactation. As a sugar-free formulation, it is suitable for individuals monitoring their sugar intake, including those with diabetes.

Brand names: Kaspro SFKaspro SF Powder
Other names: Kaspro Sugar Free

Beyond the preview

Go deeper on Kaspro SF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kaspro SF.

Explore the full profile